Surrogate end points and their role in clinical trials: Reply from authors.
Autor: | Kalikar MV; Department of Pharmacology, Government Medical College, Nagpur, India., Thawani VR, Varadpande UK, Sontakke SD, Singh RP, Khiyani RK |
---|---|
Jazyk: | angličtina |
Zdroj: | Indian journal of pharmacology [Indian J Pharmacol] 2009 Feb; Vol. 41 (1), pp. 55. |
DOI: | 10.4103/0253-7613.48879 |
Databáze: | MEDLINE |
Externí odkaz: |